Where do Monopar Therapeutics's ratios come from?

Every ratio is computed from Monopar Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-15.9%-1.6pp	-14.2%+12.3pp	-26.5%+32.8pp	-59.4%-5.1pp	-54.3%-2.8pp
Return on assets	-15.5%-1.9pp	-13.6%+12.2pp	-25.9%+30.8pp	-56.7%-4.9pp	-51.8%-5.7pp
Return on invested capital	-38.6%—	——	——	——	——
Efficiency
Asset turnover	0×—	0×—	0×—	0×—	0×—
Liquidity
Current ratio	56×+4.7×	51.4×-4.7×	56.1×+22.2×	33.9×—	——
Quick ratio	56×+4.7×	51.4×-4.7×	56.1×+22.2×	33.9×—	——
Cash ratio	21.4×-1.2×	22.6×-27.1×	49.7×+24.8×	24.9×—	——
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×—
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×—
Valuation
Market capitalization	$587.04M+192%	$436.37M-13.4%	$503.9M+147%	$203.64M-8.4%	$222.19M+65.6%
Enterprise value	$534.72M+232%	$374.78M-0.4%	$376.33M+129%	$164.25M-10.0%	$182.49M—
Price / book	4.3×+0.6×	3.2×-0.4×	3.6×-0.3×	3.9×-0.2×	4.1×+1.7×
Earnings yield	-2.6%+5.7pp	-3.1%+0.7pp	-3.9%+4.6pp	-8.5%-1.0pp	-7.5%+4.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Monopar Therapeutics's ratios come from?: Every ratio is computed from Monopar Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.